US Patent Issued to China Medical University, AXR Pharma on Aug. 26 for "Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesis and inhibiting senescence of brain neurons" (Taiwanese Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,397,034, issued on Aug. 26, was assigned to China Medical University (Taichung, Taiwan) and AXR Pharma Inc. (Taipei, Taiwan).

"Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesis and inhibiting senescence of brain neurons" was invented by Yun-Lian Lin (Taipei, Taiwan), Wei-Hsiang Hsu (Kaohsiung, Taiwan) and Young-Ji Shiao (Taipei, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition and a method of utilizing Gastrodia elata extract or an adenosine analog to promote neurogenesis, wherein the G. elata extract includes gastrodin, gastrodigenin, parishins, N6-(4-hydroxyb...